Proshares Trust ZBIO
ZBIO
$26.97 +0.21 (+0.78%)
At close: Sep 30, 2026 · 4:00 PM EDT

Zenas BioPharma (ZBIO) Convertible Debt (2023)

Updated

Zenas BioPharma's Convertible Debt came in at $20.3 million for Q4 2023.

Analysis

Zenas BioPharma (ZBIO) Convertible Debt (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Zenas BioPharma 1.69 Bn 1.69 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 20.30 Mn
API Access

Zenas BioPharma Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=ZBIO&period=max&api_key=YOUR_API_KEY